BACKGROUND: Data regarding the possible effects of estrogen on ghrelin secretion in humans are limited and contradictory. AIM: To investigate the effect of estradiol (E2) on ghrelin levels in normal pre- and post-menopausal women. SUBJECTS AND METHODS: A total of 21 women divided into 3 groups, i.e.13 normally cycling women (no.=7, group 1 and no.=6, group 2) and 8 post-menopausal women (group 3). Women of group 1 received increasing doses of E2 through skin patches from cycle days 3 to 5. Women of group 2, underwent total abdominal hysterectomy plus bilateral salpingo-oophorectomy (TAH+BSO) on cycle day 3. Women of group 3 received po increasing doses of E2 valerate for 15 days. Acylated ghrelin and E2 were measured in all blood samples. RESULTS: In group 1, plasma ghrelin levels did not show any significant changes for the week following cycle day 3. In group 2, ghrelin levels were similar before and after TAH+BSO and remained stable during the first 7 post-operative days. In group 3, no significant changes in plasma ghrelin levels were seen during the 15 days of E2 administration. CONCLUSIONS: The present study demonstrates for the first time that ghrelin values were not affected either by exogenous short-term estrogen administration to pre- and post-menopausal women or following ovariectomy in pre-menopausal women. It is suggested that ovarian hormones are not involved in the regulation of ghrelin secretion in women.
BACKGROUND: Data regarding the possible effects of estrogen on ghrelin secretion in humans are limited and contradictory. AIM: To investigate the effect of estradiol (E2) on ghrelin levels in normal pre- and post-menopausal women. SUBJECTS AND METHODS: A total of 21 women divided into 3 groups, i.e.13 normally cycling women (no.=7, group 1 and no.=6, group 2) and 8 post-menopausal women (group 3). Women of group 1 received increasing doses of E2 through skin patches from cycle days 3 to 5. Women of group 2, underwent total abdominal hysterectomy plus bilateral salpingo-oophorectomy (TAH+BSO) on cycle day 3. Women of group 3 received po increasing doses of E2 valerate for 15 days. Acylated ghrelin and E2 were measured in all blood samples. RESULTS: In group 1, plasma ghrelin levels did not show any significant changes for the week following cycle day 3. In group 2, ghrelin levels were similar before and after TAH+BSO and remained stable during the first 7 post-operative days. In group 3, no significant changes in plasma ghrelin levels were seen during the 15 days of E2 administration. CONCLUSIONS: The present study demonstrates for the first time that ghrelin values were not affected either by exogenous short-term estrogen administration to pre- and post-menopausal women or following ovariectomy in pre-menopausal women. It is suggested that ovarian hormones are not involved in the regulation of ghrelin secretion in women.
Authors: K Dafopoulos; I Mademtzis; P Vanakara; A Kallitsaris; G Stamatiou; C Kotsovassilis; I E Messinis Journal: J Clin Endocrinol Metab Date: 2005-12-06 Impact factor: 5.958
Authors: H Ariyasu; K Takaya; T Tagami; Y Ogawa; K Hosoda; T Akamizu; M Suda; T Koh; K Natsui; S Toyooka; G Shirakami; T Usui; A Shimatsu; K Doi; H Hosoda; M Kojima; K Kangawa; K Nakao Journal: J Clin Endocrinol Metab Date: 2001-10 Impact factor: 5.958
Authors: Mary Jane De Souza; Heather J Leidy; Emma O'Donnell; Bill Lasley; Nancy I Williams Journal: J Clin Endocrinol Metab Date: 2004-07 Impact factor: 5.958
Authors: Ralf Nass; Alexander Nikolayev; Jianhua Liu; Suzan S Pezzoli; Leon S Farhy; James Patrie; Bruce D Gaylinn; Mark Heiman; Michael O Thorner Journal: J Clin Endocrinol Metab Date: 2015-01 Impact factor: 5.958
Authors: Johanna K Ihalainen; Ida Löfberg; Anna Kotkajuuri; Heikki Kyröläinen; Anthony C Hackney; Ritva S Taipale-Mikkonen Journal: Endocrines Date: 2021-04-16
Authors: Ayad Mohammed Salem; Rabia Latif; Nazish Rafique; Mubarak I Aldawlan; Layan B Almulla; Duaa Y Alghirash; Ola A Fallatah; Faleh M Alotaibi; Fahad H Aljabbari; Talay Yar Journal: Int J Womens Health Date: 2022-09-07